Analysis of Positive Human Immunodeficiency Virus (1＋2) Antibodies in Preliminary Screening: A Report of 394 Cases

Objective: To comprehend the characteristics of patients with positive human immunodeficiency virus (HIV) (1＋2) antibodies in the preliminary screening so as to provide basis for local HIV screening and prevention. Methods: Enzyme-linked immunosorbent assay (ELISA) was used to detect serum HIV (1＋2) antibodies in the preliminary screening, after which the positive serum was sent to acquired immune deficiency syndrome (AIDS) confirmatory laboratory to be confirmed with western blotting method. Clinical data of patients with positive HIV antibodies in the preliminary screening in the outpatients and inpatients from 2006 to 2013 were collected and analyzed. Results: A total of 394 patients with positive serum HIV antibodies were screened initially, in which 214 were confirmed positive HIV, 13 were not certain and another 167 were negative. Patients with positive serum HIV antibodies in the preliminary screening were increased from 9 cases in 2006 to 94 cases in 2013, in which those confirmed with positive HIV increased from 5 to 49. Patients with positive serum HIV antibodies in the preliminary screening and those confirmed increased annually. In addition, patients confirmed with positive serum HIV antibodies were mainly males and aged 20～49 years, distributing in Departments of Infections, Respiratory, Dermatology, Hematology and Emergency, whereas those confirmed with negative HIV were mainly females and aged ＞20 years, distributing in Departments of Hematology, Maternity and Emergency as well as Reproductive Center. Conclusion: HIV infection is in low level with characteristics of annually increasing infection rate, male-orientated and wide-spread distribution in variuos departments, etc., knowing which will help guide the clinical practices and carry out the local HIV screening and prevention by relevant departments